DailyDime

The fundraising tool that replaced convertible notes at the seed stage, and why founders who don’t model the math carefully end up giving away more than they planned.

If you’ve spent any time in the startup world, you’ve probably heard someone casually drop “SAFE” into conversation and nodded along like you totally knew what they meant.

No shame. Let’s fix that.

SAFE stands for Simple Agreement for Future Equity. An investor gives a startup money today in exchange for equity later. No shares yet. No valuation debate. Just a binding legal contract that says: we’ll figure out the details when the time is right. (And yes, it’s binding, not a gentlemen’s agreement. In a dissolution scenario, SAFE holders have a preference over common stockholders, meaning founders and employees, to recover their money first.)

Y Combinator invented the SAFE in 2013 to make early-stage fundraising faster, cheaper, and less contentious. Over a decade later, it’s become the default instrument for seed-stage rounds across Silicon Valley and beyond. Outside the U.S., variations like ASAs in the UK or KISSes are still common due to local tax rules like SEIS/EIS, but the mechanics are similar.

Here’s how they work.

Why Did SAFEs Even Need to Exist?

Before SAFEs, startups used convertible notes. Convertible notes are loans: they carry interest, have maturity dates, and sit on the balance sheet as debt.

Debt is complicated. If a startup didn’t raise its next round before the note matured, founders could suddenly find themselves in a standoff with investors. Lawyers got involved. Negotiations dragged on.

Y Combinator’s answer: strip out the interest rate, remove the maturity date, and declare the whole thing not-a-loan. What remained was a clean contract: give us money now, get equity when the company raises a real round.

Fundraising went from weeks of legal back-and-forth to a few days of signatures.

How a SAFE Actually Works

When an investor signs a SAFE, they’re not buying shares. They’re buying the right to receive shares later, typically when the company raises a priced equity round like a Series A.

At that point, the SAFE “converts” into actual equity. How much equity depends on two key mechanisms.

The Valuation Cap

The cap sets a ceiling on the valuation used to calculate the investor’s equity at conversion. It protects early investors if the company’s value surges before a priced round.

How it plays out depends on where the Series A lands:

If the Series A valuation is higher than the cap, the investor converts at the capped valuation, giving them more shares than new investors paying the full price. Example: a $250,000 investment with a $5 million cap, into a company that raises a Series A at $15 million pre-money. Without a cap, that $250K represents a 1.67% stake. With the cap, the math runs at $5 million, and the investor ends up with roughly three times as many shares.

If the Series A valuation equals or falls below the cap, the cap is irrelevant. The investor converts at the actual Series A price. The protection existed; it just wasn’t needed.

The cap is most valuable when the company grows fast. The bigger the gap between the cap and the eventual round price, the better the deal for the early investor.

The Discount Rate

A discount rate gives SAFE investors a reduced price per share at conversion relative to new investors in the priced round. It rewards early risk without requiring a valuation negotiation upfront. Discounts typically run 10% to 25%, with 20% as the clear standard.

At a 20% discount, if the Series A prices shares at $1.00, the SAFE converts at $0.80. More shares for the same dollars.

At 25%, conversion drops to $0.75. Less common, and usually signals the investor is taking on meaningful risk without cap protection.

One limit: the discount only applies to the qualifying financing. If the company raises at a very high valuation, a discount alone may not get investors close to the economics a cap would have provided. That’s why many push for both.

When a SAFE Has Both a Cap and a Discount

Both terms in the same SAFE aren’t redundant. They protect the investor across different scenarios, and the investor gets whichever produces the lower conversion price at the moment of conversion.

Say you hold a SAFE with a $5 million cap and a 20% discount. The Series A comes in at $10 million pre-money, with a share price of $1.00.

Cap path: converting at $5M on a $10M round gives an effective price of $0.50 per share. Discount path: 20% off $1.00 gives $0.80. The cap wins.

Run the same scenario with a Series A at $6 million. The cap gives roughly $0.83; the discount gives $0.80. The discount wins, barely.

The relationship shifts based on how far the round valuation moves above the cap. At valuations near the cap, the discount often wins. At high valuations well above the cap, the cap dominates by a wide margin. Sophisticated investors want both because they can’t know in advance which scenario will materialize.

Founders should model both paths before signing. A dual-term SAFE is almost always more dilutive than it looks on first read.

What the Data Shows

SAFE terms have converged around a predictable range, shaped largely by YC’s standard documents and the norms that followed.

Cap-only SAFEs are the most common structure. Research from Kauffman Fellows and various VC databases puts them at 60% to 70% of pre-seed deals. The cap is the primary economic protection, easy to model, and requires only one variable to negotiate. Founders tend to prefer it for that reason.

Dual-term SAFEs (cap plus discount) show up in roughly 20% to 30% of deals, more often in competitive angel markets or high-risk situations like pre-product companies or first-time founders.

Discount-only SAFEs are largely a relic. Without a cap, a 20% discount on a $50 million Series A leaves the early investor far behind where a modest cap would have put them. Most sophisticated angels won’t accept this structure.

On cap levels, data from AngelList and Carta shows median pre-seed caps have risen to the $8 million to $12 million range, up from $3 million to $5 million a decade ago. Caps below $5 million are now rare outside very early pre-product rounds.

On discount rates, 20% remains the standard. Rates above 20% typically signal investor leverage or a company struggling to raise. Rates below 20% appear when founders have room to push back.

Pre-Money vs. Post-Money SAFEs: The One That Trips Founders Up

This is the number one mistake founders make with SAFEs, so pay attention.

In 2018, YC updated its standard documents and introduced a distinction that matters more than it sounds: pre-money vs. post-money SAFEs.

The post-money SAFE, now the standard, calculates the investor’s ownership after accounting for the shares from that SAFE and all other outstanding SAFEs, but before the new money and shares from the priced round itself. The investor knows exactly what percentage they own immediately before the Series A investors write their checks. Dilution from the Series A then hits SAFE holders and founders equally.

Here’s why this bites founders: those who model their cap table using pre-money logic but sign post-money SAFEs end up with significantly more dilution than expected once everything converts at the Series A. Stack multiple SAFEs from different investors with different caps, and that math compounds fast. Model it before you sign, not after.

The Pros and Cons

SAFEs aren’t magic. Like any instrument, they come with trade-offs.

For founders, the upside is speed and simplicity. No interest accruing, no maturity deadline, no debt on the balance sheet. You can raise from multiple investors on a rolling basis. The risk is losing track of how much dilution is stacking up across multiple SAFEs with different terms. By the time a Series A closes and everything converts, the math can be jarring.

For investors, the upside is early access to high-growth companies with downside protection baked into the cap. No overhead from managing interest or repayment schedules. The risk is that a SAFE offers no guaranteed return. If the company never raises a priced round, the SAFE just sits there indefinitely. No maturity date, no interest. The bet is entirely on the company’s future.

SAFEs vs. Convertible Notes

Both instruments let investors in without requiring a formal valuation. But they’re meaningfully different:

Convertible notes give investors more leverage if things stall out. SAFEs are simpler and more founder friendly. Most U.S. seed rounds now default to SAFEs, though convertible notes still show up in bridge financings and markets where investors prefer traditional debt instruments.

When a SAFE Makes Sense

A SAFE fits best when the company is pre-revenue or very early stage, the round is small (pre-seed or seed), speed matters, and both sides have a strong working relationship.

A priced equity round makes more sense when the company has meaningful traction, institutional investors are leading, or everyone needs a clean ownership structure from day one.

The Bottom Line

SAFEs reshaped early-stage startup finance by removing friction. No interest, no deadlines, no debt. Just a clean promise that early believers will be rewarded when the company grows.

For founders, that means faster fundraising and more time building. For investors, early access before valuations balloon.

“Simple” doesn’t mean “without risk,” though. Founders who don’t model dilution carefully, especially across stacked post-money SAFEs, can face a rude awakening at their Series A. Investors who don’t think about liquidity timelines can find themselves waiting years for a return, or never getting one. The mechanics are learnable. The founders and investors who take the time to understand them use SAFEs as the powerful tool they are, rather than just signing because everyone else does.